A poster encouraging parents to work with student assistance professionals when they are concerned about their child’s health and wellbeing.

A poster encouraging parents to work with student assistance professionals when they are concerned about their child’s health and wellbeing.

A poster encouraging educators to work with student assistance professionals when they are concerned about a student’s health and wellbeing.

A poster encouraging educators to work with student assistance professionals when they are concerned about a student’s health and wellbeing.

A poster encouraging educators to work with student assistance professionals when they are concerned about a student’s health and wellbeing.

A poster encouraging educators to work with student assistance professionals when they are concerned about a student’s health and wellbeing.

A poster encouraging educators to work with student assistance professionals when they are concerned about a student’s health and wellbeing.

A poster encouraging parents to work with student assistance professionals when they are concerned about their child’s health and wellbeing.

The Executive Summary of this Treatment Improvement Protocol provides an overview on the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery.

This Treatment Improvement Protocol (TIP) reviews the use of the three Food and Drug Administration (FDA)-approved medications used to treat OUD—methadone, naltrexone, and buprenorphine—and the other strategies and services needed to support recovery for people with OUD. This is a revision.